Target intelligence / Profile preview

Bacterial outer membrane permeability barrier

Molecular classification
Other (refers to a multi-component membrane property; involves outer membrane proteins, porins, lipopolysaccharide, lipoproteins, etc., but is not a defined molecular family)
01

Overview

The bacterial outer membrane permeability barrier is a distinctive feature of Gram-negative bacteria, functioning as an asymmetric lipid bilayer comprised of phospholipids (inner leaflet), lipopolysaccharide (outer leaflet), outer membrane proteins (porins), and lipoproteins[2][3][5]. This barrier serves to protect bacteria from hostile elements in their environment by preventing the entry of toxic substances, including many antibiotics, while still permitting selective uptake of nutrients through porins. Manipulation of this barrier, usually by disrupting its structure with compounds such as polymyxins or by inhibiting efflux pumps, is a recognized pharmacological strategy to increase bacterial susceptibility to antibiotics. However, the permeability barrier itself is not a single molecular target, but an emergent property of the membrane’s overall composition and organization[2][3][5][6].

Other names
Outer membrane permeabilityOM permeabilityGram-negative bacterial outer membrane
02

Mechanism of action

Disruption or destabilization of outer membrane structure (e.g., polymyxins bind LPS, displacing stabilizing cations, leading to increased permeability and cell death) Enhancement of permeability to allow entry of otherwise excluded antibiotics

03

Biological functions

Selective permeability barrierProtection from toxic compoundsRegulation of nutrient uptakeMaintenance of cell integrity
04

Disease associations

Infection (enables antibiotic resistance, major determinant of Gram-negative bacterial pathogenicity and treatment failure)Prevents host defense molecule entry
05

Safety considerations

High toxicity of OM-disrupting drugs (notably polymyxins cause nephrotoxicity and neurotoxicity in humans)Lack of specificity (broad activity may damage non-target bacteria or host membranes)Bacterial evolution of resistance through modification of OM structure (e.g., LPS modification reduces drug binding)
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

No single moleculeOM permeability assays use fluorescent probes such as 1-N-phenylnaphthylamine (NPN)

Beyond the preview

Go deeper on Bacterial outer membrane permeability barrier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial outer membrane permeability barrier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call